CNS Pharmaceuticals (CNSP) Prepaid Assets (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Prepaid Assets came in at $856301.0 in Q4 2025, down 33.82% YoY from $1.3 million in Q4 2024, and down 42.3% on a QoQ basis from $1.5 million in Q3 2025.
CNS Pharmaceuticals (CNSP) Prepaid Assets (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Prepaid Assets data on file, last reported at $856301.0 in Q4 2025.
- Quarterly Prepaid Assets fell 33.82% year-over-year to $856301.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $856301.0 (down 33.82% YoY) and the FY2025 annual result came in at $856301.0, down 33.82% from the prior year.
- Prepaid Assets slipped to $856301.0 in Q4 2025, from $1.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.3 million in Q2 2021 to a low of $388042.0 in Q3 2024.
- A 5-year average of $1.6 million and a median of $1.6 million in 2021 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 66.54% — and 2025, when it surged 282.42%.
- Tracing CNSP's Prepaid Assets over 5 years: stood at $2.5 million in 2021, then increased by 1.47% to $2.5 million in 2022, then plunged by 66.54% to $839590.0 in 2023, then surged by 54.12% to $1.3 million in 2024, then sank by 33.82% to $856301.0 in 2025.
- The last three Prepaid Assets figures came in at $856301.0 (Q4 2025), $1.5 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 856,301.00 |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 653,797.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 388,042.00 |
| Jun 30, 2024 | 637,087.00 |
| Mar 31, 2024 | 786,050.00 |
| Dec 31, 2023 | 839,590.00 |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 2.83 Mn |
| Jun 30, 2021 | 3.30 Mn |
| Mar 31, 2021 | 1.58 Mn |